St. Joseph Medical Center in Tacoma, Washington, is the flagship hospital of the Franciscan Health System, based in Tacoma. Franciscan is affiliated with Catholic Health Initiatives, a national nonprofit organization with headquarters in Englewood, Colo.

During the past decade, Saint Joseph Medical Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 87 clinical trials were completed, i.e. on average, 669.2% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 34 clinical trials were completed. i.e. 1700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Joseph Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 45 trials, followed by "National Cancer Institute (NCI)" with 41 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "NSABP Foundation Inc" with 8 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Joseph Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 85 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Cancer and Leukemia Group B" with 14 trials as a collaborator, "NCIC Clinical Trials Group" with 12 trials as a collaborator and "SWOG Cancer Research Network" with 10 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Saint Joseph Medical Center" are "Breast Cancer" (21 trials), "Lung Cancer" (12 trials), "Prostate Cancer" (9 trials), "Lymphoma" (7 trials) and "Recurrent Squamous Cell Lung Carcinoma" (7 trials). Many other conditions were trialed in "Saint Joseph Medical Center" in a lesser frequency.

Most popular intervention types in "Saint Joseph Medical Center" are "Drug" (110 trials), "Other" (74 trials), "Biological" (46 trials), "Radiation" (21 trials) and "Procedure" (18 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (43 trials), "Paclitaxel" (23 trials), "Quality-of-Life Assessment" (21 trials), "Bevacizumab" (17 trials) and "Carboplatin" (15 trials). Other intervention names were less common.

The vast majority of trials in "Saint Joseph Medical Center" are 86 trials for "All" genders, 45 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Joseph Medical Center". undefined are not yet recruiting, 2 are recruiting, 41 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 83 completed trials in Saint Joseph Medical Center, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Joseph Medical Center, 1 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 90 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".